143 related articles for article (PubMed ID: 17978303)
1. Pneumocystis pneumonia associated with infliximab in Japan.
Harigai M; Koike R; Miyasaka N;
N Engl J Med; 2007 Nov; 357(18):1874-6. PubMed ID: 17978303
[No Abstract] [Full Text] [Related]
2. Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis.
Teichmann LL; Woenckhaus M; Vogel C; Salzberger B; Schölmerich J; Fleck M
Rheumatology (Oxford); 2008 Aug; 47(8):1256-7. PubMed ID: 18567919
[No Abstract] [Full Text] [Related]
3. Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis.
Takeuchi T; Tatsuki Y; Nogami Y; Ishiguro N; Tanaka Y; Yamanaka H; Kamatani N; Harigai M; Ryu J; Inoue K; Kondo H; Inokuma S; Ochi T; Koike T
Ann Rheum Dis; 2008 Feb; 67(2):189-94. PubMed ID: 17644554
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor alpha neutralizing antibody.
Mori S; Imamura F; Kiyofuji C; Ito K; Koga Y; Honda I; Sugimoto M
Mod Rheumatol; 2006; 16(1):58-62. PubMed ID: 16622728
[TBL] [Abstract][Full Text] [Related]
5. [Pneumonia, pneumocystis pneumonia].
Koike R; Harigai M
Nihon Rinsho; 2007 Jul; 65(7):1314-20. PubMed ID: 17642249
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients.
Komano Y; Harigai M; Koike R; Sugiyama H; Ogawa J; Saito K; Sekiguchi N; Inoo M; Onishi I; Ohashi H; Amamoto F; Miyata M; Ohtsubo H; Hiramatsu K; Iwamoto M; Minota S; Matsuoka N; Kageyama G; Imaizumi K; Tokuda H; Okochi Y; Kudo K; Tanaka Y; Takeuchi T; Miyasaka N
Arthritis Rheum; 2009 Mar; 61(3):305-12. PubMed ID: 19248121
[TBL] [Abstract][Full Text] [Related]
7. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.
Lee JH; Slifman NR; Gershon SK; Edwards ET; Schwieterman WD; Siegel JN; Wise RP; Brown SL; Udall JN; Braun MM
Arthritis Rheum; 2002 Oct; 46(10):2565-70. PubMed ID: 12384912
[TBL] [Abstract][Full Text] [Related]
8. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
Gómez-Reino JJ; Carmona L; Valverde VR; Mola EM; Montero MD;
Arthritis Rheum; 2003 Aug; 48(8):2122-7. PubMed ID: 12905464
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of brucellosis after treatment with infliximab in a patient with rheumatoid arthritis.
Jiménez FG; Colmenero JD; Irigoyen MV
J Infect; 2005 May; 50(4):370-1. PubMed ID: 15845443
[No Abstract] [Full Text] [Related]
10. Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis.
Geraghty EM; Ristow B; Gordon SM; Aronowitz P
Clin Infect Dis; 2007 May; 44(10):e82-4. PubMed ID: 17443458
[TBL] [Abstract][Full Text] [Related]
11. Atypical cutaneous tuberculosis in a patient with rheumatoid arthritis treated with infliximab.
Asano Y; Kano Y; Shiohara T
Acta Derm Venereol; 2008; 88(2):183-4. PubMed ID: 18311458
[No Abstract] [Full Text] [Related]
12. Pneumocystis carinii pneumonia following a second infusion of infliximab.
Tai TL; O'Rourke KP; McWeeney M; Burke CM; Sheehan K; Barry M
Rheumatology (Oxford); 2002 Aug; 41(8):951-2. PubMed ID: 12154220
[No Abstract] [Full Text] [Related]
13. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.
Ostör AJ; Chilvers ER; Somerville MF; Lim AY; Lane SE; Crisp AJ; Scott DG
J Rheumatol; 2006 Mar; 33(3):622-8. PubMed ID: 16511933
[TBL] [Abstract][Full Text] [Related]
14. Cryptococcal meningitis in a patient treated with infliximab.
Muñoz P; Giannella M; Valerio M; Soria T; Díaz F; Longo JL; Bouza E
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):443-6. PubMed ID: 17240111
[TBL] [Abstract][Full Text] [Related]
15. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.
Wolfe F; Caplan L; Michaud K
Arthritis Rheum; 2006 Feb; 54(2):628-34. PubMed ID: 16447241
[TBL] [Abstract][Full Text] [Related]
16. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles.
Ettefagh L; Nedorost S; Mirmirani P
Arch Dermatol; 2004 Aug; 140(8):1012. PubMed ID: 15313825
[No Abstract] [Full Text] [Related]
17. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
Gilaberte Y; Coscojuela C; Vázquez C; Roselló R; Vera J
Br J Dermatol; 2007 Feb; 156(2):368-71. PubMed ID: 17223880
[TBL] [Abstract][Full Text] [Related]
18. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
Chan CY; Browning JC; Larsen F; Hsu S
Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of respiratory infection complicating treatment with infliximab].
Kasai S; Tokuda H; Otsuka Y; Ookohchi Y; Handa H; Emoto N; Yoshikawa M
Nihon Kokyuki Gakkai Zasshi; 2007 Apr; 45(4):366-71. PubMed ID: 17491318
[TBL] [Abstract][Full Text] [Related]
20. Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice.
Neven N; Vis M; Voskuyl AE; Wolbink GJ; Nurmohamed MT; Dijkmans BA; Lems WF
Ann Rheum Dis; 2005 Apr; 64(4):645-6. PubMed ID: 15769924
[No Abstract] [Full Text] [Related]
[Next] [New Search]
